解剖病理市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、技術別、用途別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

解剖病理の世界市場規模は、2024年に360億9,000万米ドルとなり、2030年までのCAGRは7.90%で、堅調な成長が予測されています。

解剖病理の世界市場は、組織や細胞を顕微鏡レベルで検査することで疾病の診断と解明を行う、ヘルスケア産業におけるダイナミックで重要な分野です。この市場には、臨床検査、診断機器、関連消耗品など、幅広い製品とサービスが含まれます。

市場促進要因

慢性疾患とがんの発生率の増加

主な市場課題

償還の問題

主な市場動向

デジタル病理学の急速な進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の解剖病理市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（組織病理学、細胞病理学、外科病理学、その他）
  • 技術別（特殊染色、免疫組織化学、電子顕微鏡検査、遺伝子検査、その他）
  • 用途別（疾患診断、新薬発見・開発）
  • エンドユーザー別（病院、研究機関、診断機関、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の解剖病理市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の解剖病理市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の解剖病理市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の解剖病理市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの解剖病理市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の解剖病理市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Quest Diagnostics Inc
• Danaher Corporation
• PHC Holdings Corporation
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche AG
• Agilent Technologies Inc.
• Cardinal Health Inc.
• Sakura Finetek USA Inc.
• NeoGenomics Laboratories Inc.
• BioGenex.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Anatomic Pathology Market was valued at USD 36.09 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 7.90% through 2030. The Global Anatomic Pathology Market is a dynamic and vital sector within the healthcare industry, dedicated to the diagnosis and understanding of diseases through the examination of tissues and cells at a microscopic level. This market encompasses a wide range of products and services, including laboratory testing, diagnostic equipment, and related consumables.

Key Market Drivers

Rising Incidence of Chronic Diseases and Cancer

The Global Anatomic Pathology Market is experiencing a notable boost due to the rising incidence of chronic diseases and cancer worldwide. This epidemiological trend has become a significant driver in the expansion of the anatomic pathology sector. For instance, The World Health Organization (WHO) estimates that in 2022, there were 20 million new cancer cases and 9.7 million cancer-related deaths worldwide. Around 53.5 million individuals were expected to survive at least five years after their initial cancer diagnosis, highlighting the ongoing global burden of the disease and the need for continued advancements in cancer detection, treatment, and survivorship care. Chronic diseases, including cardiovascular diseases, diabetes, and respiratory conditions, have been steadily increasing in prevalence, primarily attributed to factors such as aging populations, sedentary lifestyles, and poor dietary choices. Similarly, cancer, one of the most formidable health challenges, continues to grow in frequency, impacting millions of lives globally.

Anatomic pathology plays an indispensable role in the diagnosis and characterization of these diseases. Pathologists examine tissue and cell samples at a microscopic level, providing critical insights into disease progression, staging, and treatment planning. In the context of cancer, precise and timely pathological analysis is essential for determining the type of cancer, its aggressiveness, and the presence of specific biomarkers. This information guides oncologists in developing personalized treatment strategies, such as targeted therapies and immunotherapies, ultimately improving patient outcomes.

As the global healthcare landscape grapples with the increasing burden of chronic diseases and cancer, the demand for anatomic pathology services continues to surge. This heightened demand is not only driven by the sheer volume of cases but also by the need for accurate and comprehensive diagnostic information. Patients and healthcare providers alike are recognizing the pivotal role that anatomic pathology plays in delivering effective and personalized care. The integration of technology, such as digital pathology and molecular diagnostics, into anatomic pathology practices has enhanced the precision and efficiency of disease diagnosis. Digital pathology enables the remote viewing and analysis of pathology slides, facilitating consultations and second opinions from experts around the world. Molecular pathology techniques allow for the examination of genetic and molecular alterations within tissues, guiding the development of targeted therapies and immunotherapies.

Key Market Challenges

Reimbursement Issues

One of the primary concerns in the anatomic pathology market is the uncertainty surrounding reimbursement rates. Pathology services encompass a wide range of diagnostic tests, including histopathology, cytology, and molecular diagnostics, which often involve the use of sophisticated technologies and equipment. However, reimbursement rates for these services may not always reflect the true cost incurred by laboratories, particularly in cases where advanced diagnostic techniques are employed. This disparity between the cost of providing services and the reimbursement received can strain the financial viability of pathology laboratories, hampering their ability to invest in state-of-the-art equipment and technologies.

The complexity of reimbursement systems and the variation in policies across different regions can further compound the challenges. Navigating the intricacies of billing, coding, and documentation requirements can be time-consuming and resource-intensive for pathology laboratories. This administrative burden not only adds overhead costs but can also lead to delays in reimbursement, affecting the cash flow of these facilities.

The impact of reimbursement issues extends beyond pathology laboratories; it can also influence patient access to advanced diagnostic services. When laboratories are constrained by inadequate reimbursement rates, they may be reluctant to offer certain tests or invest in the latest technologies.

Key Market Trends

Rapid Advancements in Digital Pathology

Rapid advancements in digital pathology are serving as a driving force behind the burgeoning Global Anatomic Pathology Market. Digital pathology, a transformative technology, involves the digitization of traditional glass pathology slides and the analysis of tissue specimens in a digital format. This innovation has been a game-changer in the field of anatomic pathology, bringing a multitude of benefits that are accelerating its growth and adoption worldwide.

One of the most significant contributions of digital pathology is its ability to improve the accuracy and efficiency of diagnostic processes. By converting glass slides into high-resolution digital images, pathologists can access and analyze tissue specimens remotely. This enables the seamless sharing of pathology slides across geographical boundaries, facilitating consultations with experts from different parts of the world. The collaborative nature of digital pathology not only enhances the quality of diagnostic decisions but also expedites patient care.

Artificial intelligence (AI) and machine learning are increasingly integrated into digital pathology platforms, opening new horizons for automation and diagnostic assistance. AI algorithms can assist pathologists in identifying abnormalities, quantifying biomarkers, and streamlining workflow processes. This trend is reducing the risk of human error, accelerating the pace of diagnosis, and ultimately improving patient outcomes. AI-driven image analysis is enabling the identification of subtle morphological patterns and molecular markers that may be challenging to detect through traditional methods.

The digital pathology is enabling the creation of vast digital archives of pathology data. These digital repositories allow for the retrospective analysis of pathology cases, which can lead to the discovery of new insights into disease progression and treatment outcomes. Researchers can harness this wealth of data to conduct retrospective studies and advance our understanding of various diseases, ultimately contributing to the development of more effective therapies.

Key Market Players

• Quest Diagnostics Inc
• Danaher Corporation
• PHC Holdings Corporation
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche AG
• Agilent Technologies Inc.
• Cardinal Health Inc.
• Sakura Finetek USA Inc.
• NeoGenomics Laboratories Inc.
• BioGenex

Report Scope:

In this report, the Global Anatomic Pathology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anatomic Pathology Market, By Type:

• Histopathology
• Cytopathology
• Surgical Pathology
• Others

Anatomic Pathology Market, By Technique:

• Special Staining
• Immunohistochemistry
• Electron Microscopy
• Genetic Testing
• Others

Anatomic Pathology Market, By Application:

• Disease Diagnosis
• Drug Discovery and Development

Anatomic Pathology Market, By End-User:

• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Others

Anatomic Pathology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anatomic Pathology Market.

Available Customizations:

Global Anatomic Pathology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Anatomic Pathology Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Histopathology, Cytopathology, Surgical Pathology, Others)
  • 4.2.2. By Technique (Special Staining, Immunohistochemistry, Electron Microscopy, Genetic Testing, Others)
  • 4.2.3. By Application (Disease Diagnosis, Drug Discovery and Development)
  • 4.2.4. By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Others)
  • 4.2.5. By Region
  • 4.2.6. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Technique
  • 4.3.3. By Application
  • 4.3.4. By End-User
  • 4.3.5. By Region

5. Asia Pacific Anatomic Pathology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Technique
  • 5.2.3. By Application
  • 5.2.4. By End-User
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Anatomic Pathology Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Technique
      • 5.3.1.2.3. By Application
      • 5.3.1.2.4. By End-User
  • 5.3.2. India Anatomic Pathology Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Technique
      • 5.3.2.2.3. By Application
      • 5.3.2.2.4. By End-User
  • 5.3.3. Australia Anatomic Pathology Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Technique
      • 5.3.3.2.3. By Application
      • 5.3.3.2.4. By End-User
  • 5.3.4. Japan Anatomic Pathology Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Technique
      • 5.3.4.2.3. By Application
      • 5.3.4.2.4. By End-User
  • 5.3.5. South Korea Anatomic Pathology Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Technique
      • 5.3.5.2.3. By Application
      • 5.3.5.2.4. By End-User

6. Europe Anatomic Pathology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Anatomic Pathology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-User
  • 6.3.2. Germany Anatomic Pathology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-User
  • 6.3.3. Spain Anatomic Pathology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-User
  • 6.3.4. Italy Anatomic Pathology Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Technique
      • 6.3.4.2.3. By Application
      • 6.3.4.2.4. By End-User
  • 6.3.5. United Kingdom Anatomic Pathology Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Technique
      • 6.3.5.2.3. By Application
      • 6.3.5.2.4. By End-User

7. North America Anatomic Pathology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technique
  • 7.2.3. By End-User
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Anatomic Pathology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-User
  • 7.3.2. Mexico Anatomic Pathology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-User
  • 7.3.3. Canada Anatomic Pathology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-User

8. South America Anatomic Pathology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technique
  • 8.2.3. By End-User
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Anatomic Pathology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-User
  • 8.3.2. Argentina Anatomic Pathology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-User
  • 8.3.3. Colombia Anatomic Pathology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-User

9. Middle East and Africa Anatomic Pathology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Anatomic Pathology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-User
  • 9.3.2. Saudi Arabia Anatomic Pathology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-User
  • 9.3.3. UAE Anatomic Pathology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Anatomic Pathology Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Quest Diagnostics Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Danaher Corporation
• 14.3. PHC Holdings Corporation
• 14.4. Laboratory Corporation of America Holdings
• 14.5. F. Hoffmann-La Roche AG
• 14.6. Agilent Technologies Inc.
• 14.7. Cardinal Health Inc.
• 14.8. Sakura Finetek USA Inc.
• 14.9. NeoGenomics Laboratories Inc.
• 14.10.BioGenex.

15. Strategic Recommendations

16. About Us & Disclaimer